Centian

Centian is a longevity-focused biotechnology company dedicated to discovering and developing therapeutics that mimic the genetic advantages of centenarians. Founded by leading experts in aging research, including Dr. Nir Barzilai and Dr. David Sinclair, the company utilizes a proprietary platform to identify rare genetic variants associated with extreme human longevity. By translating these genetic insights into drug targets, Centian aims to treat a broad spectrum of age-related diseases and extend healthy human lifespan. The company's research focuses on identifying protective alleles that allow certain individuals to live past 100 years in good health. Centian's pipeline primarily targets pathways involved in metabolic regulation, proteostasis, and cellular resilience. The company operates at the intersection of human genetics, bioinformatics, and drug discovery to create a new class of longevity-mimetic medicines.